LV10047A - Medetomidina saju un to optiski aktivo enantiomeru izmantosana medicinisko preperatu transdermalas iedarbibas pakapes regulesanai - Google Patents

Medetomidina saju un to optiski aktivo enantiomeru izmantosana medicinisko preperatu transdermalas iedarbibas pakapes regulesanai

Info

Publication number
LV10047A
LV10047A LV920018A LV920018A LV10047A LV 10047 A LV10047 A LV 10047A LV 920018 A LV920018 A LV 920018A LV 920018 A LV920018 A LV 920018A LV 10047 A LV10047 A LV 10047A
Authority
LV
Latvia
Prior art keywords
medetomidine
optically active
bonds
regulation
active enantiomers
Prior art date
Application number
LV920018A
Other languages
English (en)
Other versions
LV10047B (en
Inventor
Harry Jalonen
Arto Johannes Karjalainen
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of LV10047A publication Critical patent/LV10047A/lv
Publication of LV10047B publication Critical patent/LV10047B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
LVP-92-18A 1991-05-31 1992-05-28 The use of certain salts of medetomidine and their optically active enantiomers to regulate the rate of transdermal administration of the drugs LV10047B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919111732A GB9111732D0 (en) 1991-05-31 1991-05-31 The use of certain salts of medetomidine and its optically active enantiomers to regulate the rate of transdermal administration of the drugs

Publications (2)

Publication Number Publication Date
LV10047A true LV10047A (lv) 1994-05-10
LV10047B LV10047B (en) 1995-02-20

Family

ID=10695876

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-92-18A LV10047B (en) 1991-05-31 1992-05-28 The use of certain salts of medetomidine and their optically active enantiomers to regulate the rate of transdermal administration of the drugs

Country Status (17)

Country Link
US (1) US5438067A (lv)
EP (1) EP0587819B1 (lv)
JP (2) JP3483881B2 (lv)
AT (1) ATE149090T1 (lv)
AU (1) AU1798192A (lv)
CA (1) CA2110161C (lv)
DE (1) DE69217658T2 (lv)
EE (1) EE03053B1 (lv)
FI (1) FI104948B (lv)
GB (2) GB9111732D0 (lv)
IE (1) IE67168B1 (lv)
LT (1) LT3130B (lv)
LV (1) LV10047B (lv)
NO (1) NO303818B1 (lv)
NZ (1) NZ242717A (lv)
WO (1) WO1992021338A1 (lv)
ZA (1) ZA923395B (lv)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5883115A (en) * 1992-11-09 1999-03-16 Pharmetrix Division Technical Chemicals & Products, Inc. Transdermal delivery of the eutomer of a chiral drug
GB2290964A (en) * 1994-07-08 1996-01-17 Arto Olavi Urtti Transdermal drug delivery system
GB9521680D0 (en) * 1995-10-23 1996-01-03 Orion Yhtymo Oy New use of imidazole derivatives
US5730721A (en) 1996-01-25 1998-03-24 Vesture Corporation Medical applicator and method
GB9614098D0 (en) 1996-07-05 1996-09-04 Orion Yhtymae Oy Transdermal delivery of levosimendan
IT1290255B1 (it) * 1997-02-05 1998-10-22 Wallcovering Pubblicita S R L Supporto sagomato aderente all'epidermide per la cessione di sostanze cosmetiche o farmacologiche e metodo per la sua fabbricazione
DE19936395C2 (de) 1999-08-03 2002-07-18 Antonia Buntz Kosmetikpflaster und Verfahren zum Anheben der weiblichen Brust mittels eines solchen Kosmetikpflasters und seine Verwendung
US6682757B1 (en) 2000-11-16 2004-01-27 Euro-Celtique, S.A. Titratable dosage transdermal delivery system
US7795263B2 (en) * 2008-07-08 2010-09-14 Wildlife Laboratories, Inc. Pharmaceutical combination for and method of anesthetizing and immobilizing non-domesticated mammals
KR101859486B1 (ko) * 2009-05-15 2018-06-28 레크로파마, 인코포레이티드 설하용 덱스메데토미딘 조성물과 그의 사용 방법
AU2011204315A1 (en) * 2010-01-08 2012-08-02 Recro Pharma, Inc. Topical transdermal dexmedetomidine compositions and methods of use thereof
US20120202863A1 (en) * 2011-02-03 2012-08-09 Gerald Horn Compositions and methods for treatment of glaucoma
EP2787970B1 (en) 2011-12-11 2018-04-11 Recro Pharma, Inc. Intranasal dexmedetomidine compositions and methods of use thereof
KR101827980B1 (ko) * 2013-10-07 2018-02-13 테이코쿠 팔마 유에스에이, 인코포레이티드 덱스메데토미딘 경피 전달 장치 및 이의 사용 방법
JP6188934B2 (ja) * 2013-10-07 2017-08-30 テイコク ファーマ ユーエスエー インコーポレーテッド デクスメデトミジン経皮組成物を含む疼痛管理用方法及び組成物
EP3054934B1 (en) * 2013-10-07 2024-05-22 Teikoku Pharma USA, Inc. Methods and compositions for treating withdrawal syndromes using non-sedative dexmedetomidine transdermal compositions
EP3054935B1 (en) * 2013-10-07 2020-12-09 Teikoku Pharma USA, Inc. Methods and compositions for treating attention deficit hyperactivity disorder, anxiety and insomnia using dexmedetomidine transdermal compositions
RU2648449C2 (ru) * 2013-10-07 2018-03-26 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. Способы и композиции для трансдермальной доставки неседативного количества дексмедетомидина
TW201609200A (zh) 2013-12-18 2016-03-16 丸石製藥股份有限公司 含水型貼劑
CN111346072B (zh) * 2018-12-21 2022-05-27 宜昌人福药业有限责任公司 一种透皮给药的药物组合物及其制备方法
JP2022531116A (ja) 2019-05-01 2022-07-06 クレキシオ バイオサイエンシーズ エルティーディー． そう痒症を治療する方法
WO2020222192A1 (en) 2019-05-01 2020-11-05 Clexio Biosciences Ltd. Methods of treating pruritus
TWI772807B (zh) 2019-05-27 2022-08-01 日商救急藥品工業股份有限公司 外用製劑

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2101114B (en) * 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
FI864570A0 (fi) 1986-11-11 1986-11-11 Farmos Oy Terapeutiskt anvaendbar foerening.
GB2206880B (en) * 1987-07-16 1991-04-24 Farmos Oy Optical isomers of an imidazole derivative
GB2215206B (en) * 1988-02-29 1991-07-03 Farmos Oy 4-substituted imidazole derivatives useful in perioperative care
US5217718A (en) * 1989-08-18 1993-06-08 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
US5124157A (en) * 1989-08-18 1992-06-23 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
US5304569A (en) * 1989-11-13 1994-04-19 Orion-Yhtyma Oy Compositions and their use in lowering intraocular pressure

Also Published As

Publication number Publication date
LT3130B (en) 1994-12-25
CA2110161A1 (en) 1992-12-10
ATE149090T1 (de) 1997-03-15
WO1992021338A1 (en) 1992-12-10
JP3483881B2 (ja) 2004-01-06
US5438067A (en) 1995-08-01
JPH06507888A (ja) 1994-09-08
EP0587819A1 (en) 1994-03-23
LV10047B (en) 1995-02-20
FI935351A (fi) 1993-11-30
IE67168B1 (en) 1996-03-06
EE03053B1 (et) 1997-12-15
GB9111732D0 (en) 1991-07-24
DE69217658D1 (de) 1997-04-03
CA2110161C (en) 2004-08-03
DE69217658T2 (de) 1997-07-03
AU1798192A (en) 1993-01-08
NO303818B1 (no) 1998-09-07
NO934323L (no) 1993-11-29
JP2003327531A (ja) 2003-11-19
GB9211033D0 (en) 1992-07-08
GB2256367B (en) 1995-03-15
EP0587819B1 (en) 1997-02-26
LTIP112A (en) 1994-07-15
ZA923395B (en) 1993-03-31
FI935351A0 (fi) 1993-11-30
NZ242717A (en) 1994-03-25
GB2256367A (en) 1992-12-09
IE921937A1 (en) 1992-12-02
NO934323D0 (no) 1993-11-29
FI104948B (fi) 2000-05-15

Similar Documents

Publication Publication Date Title
LV10047A (lv) Medetomidina saju un to optiski aktivo enantiomeru izmantosana medicinisko preperatu transdermalas iedarbibas pakapes regulesanai
ATE216240T1 (de) Transdermales therapeutisches system mit galanthamin als wirksamen bestandteil
DK581685A (da) Transderimalt system for timolol-indgift
ATE5563T1 (de) Therapeutisches system zum zufuehren von arzneimitteln zur haut.
NO920521D0 (no) Fremgangsmaate og anordning for administrering av deksmedetomidin transdermalt
FI952269A0 (fi) Ihonläpäisevä terapeuttinen järjestelmä fysostigmiinin antamiseen iholle ja menetelmä järjestelmän valmistamiseksi